BioCentury | Oct 10, 2011
Finance

Venture's stress

...Jan 2006; acquired by Eli Lilly and Co. (NYSE:LLY) in Aug 2008 for$64M in cash Signature BioScience Inc....
BioCentury | May 31, 2010
Company News

Amarantus management update

...Business: Neurology, Cardiovascular Hired: Robert Zimmerman as chief development officer, formerly president and COO of Signature BioScience Inc....
BioCentury | Aug 29, 2005
Strategy

Thinking commercial

...its own efforts. That is when the board tapped McDade, who had been CEO of Signature BioScience Inc....
BioCentury | May 5, 2003
Company News

Signature cancer, high throughput screening news

...Ventures; MDS Capital; China Development Industrial Bank; Tallwood Venture Capital; Lehman Brothers; and Lotus BioScience. Signature BioScience Inc....
BioCentury | May 5, 2003
Finance

Ebb & Flow

...trying to transition from "platform" to "product" may learn some lessons from the failure of Signature BioScience...
BioCentury | Nov 11, 2002
Company News

Signature management update

Signature Bioscience Inc. , San Francisco, Calif. Business: Cancer Promoted: Robert Zimmerman to president and a director from EVP of R&D; he remains COO Departed: Mark McDade as CEO, while remaining chairman WIR Staff cancer...
BioCentury | Nov 11, 2002
Company News

Protein Design Labs management update

...Business: Antibodies, Cancer, Autoimmune/Inflammation Hired: Mark McDade as CEO and a director, formerly CEO of Signature BioScience Inc. WIR...
BioCentury | Nov 5, 2002
Company News

McDade joins PDLI as CEO

...director, effective Dec. 2. McDade was most recently CEO of small molecule cancer therapeutic developer Signature BioScience...
BioCentury | Oct 7, 2002
Finance

Take the cash

...a secondary concern." "Dilution is a lot better than death," noted Mark McDade, CEO of Signature BioScience Inc....
BioCentury | Sep 23, 2002
Company News

Signature Bioscience management update

Signature Bioscience , San Francisco, Calif. Business: Chemistry, Bioinformatics Hired: Robert Zimmerman as COO and EVP of R&D, formerly VP of biotechnology research at Bayer Corp. WIR Staff...
Items per page:
1 - 10 of 46
BioCentury | Oct 10, 2011
Finance

Venture's stress

...Jan 2006; acquired by Eli Lilly and Co. (NYSE:LLY) in Aug 2008 for$64M in cash Signature BioScience Inc....
BioCentury | May 31, 2010
Company News

Amarantus management update

...Business: Neurology, Cardiovascular Hired: Robert Zimmerman as chief development officer, formerly president and COO of Signature BioScience Inc....
BioCentury | Aug 29, 2005
Strategy

Thinking commercial

...its own efforts. That is when the board tapped McDade, who had been CEO of Signature BioScience Inc....
BioCentury | May 5, 2003
Company News

Signature cancer, high throughput screening news

...Ventures; MDS Capital; China Development Industrial Bank; Tallwood Venture Capital; Lehman Brothers; and Lotus BioScience. Signature BioScience Inc....
BioCentury | May 5, 2003
Finance

Ebb & Flow

...trying to transition from "platform" to "product" may learn some lessons from the failure of Signature BioScience...
BioCentury | Nov 11, 2002
Company News

Signature management update

Signature Bioscience Inc. , San Francisco, Calif. Business: Cancer Promoted: Robert Zimmerman to president and a director from EVP of R&D; he remains COO Departed: Mark McDade as CEO, while remaining chairman WIR Staff cancer...
BioCentury | Nov 11, 2002
Company News

Protein Design Labs management update

...Business: Antibodies, Cancer, Autoimmune/Inflammation Hired: Mark McDade as CEO and a director, formerly CEO of Signature BioScience Inc. WIR...
BioCentury | Nov 5, 2002
Company News

McDade joins PDLI as CEO

...director, effective Dec. 2. McDade was most recently CEO of small molecule cancer therapeutic developer Signature BioScience...
BioCentury | Oct 7, 2002
Finance

Take the cash

...a secondary concern." "Dilution is a lot better than death," noted Mark McDade, CEO of Signature BioScience Inc....
BioCentury | Sep 23, 2002
Company News

Signature Bioscience management update

Signature Bioscience , San Francisco, Calif. Business: Chemistry, Bioinformatics Hired: Robert Zimmerman as COO and EVP of R&D, formerly VP of biotechnology research at Bayer Corp. WIR Staff...
Items per page:
1 - 10 of 46